meta_pixel
Tapesearch Logo
Log in
Industry Focus

Healthcare: Apple's Cure for Soaring Costs? Tech-Savvy Healthcare Clinics

Industry Focus

The Motley Fool

Interview, Money, Consumergoods, Business, Businessnews, Ceo, Technology, Investing, Stocks, Energy, Fool, Financial, Economy, Healthcare, News, Banking, Motley, Tech, Business News, Investments

4.6854 Ratings

🗓️ 28 February 2018

⏱️ 20 minutes

🧾️ Download transcript

Summary

The Cupertino company plans to open healthcare clinics that will rely heavily on its technology. Also, Gilead Sciences partners with Sangamo Therapeutics on gene-editing.

Thanks to LegalZoom for supporting Motley Fool. Get special savings by going to legalzoom.com use code Fool at checkout.

Transcript

Click on a timestamp to play from that location

0:00.0

Thanks to legal zoom for supporting the Motley Fool.

0:02.6

Whether you want to take your business to the next level

0:04.9

or take control of your family's future

0:06.7

within a state plan, legal zoom is where to start.

0:09.6

They're not a law firm, but their network of independent attorneys

0:12.4

can help keep you on track.

0:14.3

For special savings, enter fool at checkout. LegalZoom.com.

0:20.8

Welcome to Industry Focus, the podcast that dives into a different sector of the stock market every day.

0:25.0

It's Wednesday, February 28th. I'm your host Christine Hargis and I'm joined via Skype by

0:29.9

full.com health care specialist Todd Campbell. Hey Todd, how are you?

0:34.0

Hi Christine, I'm well. Glad to be on the show today. It's going to be a fun one.

0:38.5

Yes, let's get right into it. Some news out of one of our most beloved biotech stocks, Gilead Sciences, last

0:46.2

Thursday, February 22nd, a collaboration between Gilead and Sengamo Therapeutics was announced.

0:53.1

This licensing deal will use Sangamo's

0:55.6

zinc finger nucleus or ZphN technology

0:59.4

to edit DNA to develop cell therapies for cancer.

1:04.2

You know what's really cool, Christine, and we're going to get into a little bit more than

1:07.8

ditty gritty as we go forward, but you think about where we may be heading in treatment from here and the whole concept of being able to go in and

1:18.0

actually replace or edit out you know these parts of our genetic code that are faulty is truly quite amazing I was thinking hey

1:26.2

maybe they can actually make my hair not be gray or but I think that they're going to focus more on

1:31.9

on some much more important things early on.

1:36.1

You know there are a few different ways that companies are researching gene editing.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.